Advanced Search

 

Study ID Status Title Patient Level Data
114653 Completed A Phase II, Open-label, Multicenter, Randomized Study to Assess the Efficacy and Safety of GSK1120212 Compared with Docetaxel in 2nd Line Subjects with Targeted Mutations (KRAS, NRAS, BRAF, MEK1) in Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC Stage IV)
114655 Completed A Phase I, Single-Sequence, Placebo-Controlled, Single-Blind Study to Evaluate the Effect of Repeat Oral Dosing of GSK1120212 on Cardiac Repolarization in Subjects with Solid Tumors
114660 Completed A randomised, double-blind, placebo-controlled, cross-over study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending oral doses of GSK2239633 in healthy male subjects. Study Listed on ClinicalStudyDataRequest.com
114677 Completed A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of A Clindamycin / Benzoyl Peroxide Gel Versus Clindamycin Gel Versus Benzoyl Peroxide Gel Versus Vehicle Gel In Subjects With Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
114693 Completed Two part study to investigate pharmacokinetics (PK) & pharmacodynamics (PD) of SB-705498, TRPV1 antagonist, in cough. Part A: open label study in healthy subjects to determine exposure to SB-705498. Part B: double-blind, placebo controlled, cross over study to investigate effect of SB-705498 on capsaicin induced cough and 24 hour cough counts in cough patients Study Listed on ClinicalStudyDataRequest.com
114700 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 vaccine when administered according to alternative 2-dose schedules in 9 - 14 year old females Study Listed on ClinicalStudyDataRequest.com
114728 Completed A multicenter, two part, randomized, parallel group, placebo and sitagliptin controlled study to evaluate the safety and efficacy of GSK256073 administered once or twice daily for 12 weeks in subjects with type 2 diabetes mellitus who are being treated with metformin Study Listed on ClinicalStudyDataRequest.com
114731 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Cumulative Irritation Potential of Topically Applied Calcipotriene Foam, 0.005% in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114738 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Potential of Topically Applied EF Calcipotriene Foam, 0.005% to Induce Contact Sensitization in Healthy Volunteers Upon Exposure to Repeated Skin Patch Applications Study Listed on ClinicalStudyDataRequest.com
114739 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied EF Calcipotriene Foam, 0.005% in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114740 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Phototoxic Potential of Topically Applied EF Calcipotriene Foam, 0.005% in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114741 Completed A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267, versus Vehicle in Subjects with Plaque-type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114742 Completed A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , versus Vehicle Foam in Subjects with Plaque-type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114743 Completed A Multicenter, Randomized, Double-Blind Study of the Safety and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam In The Treatment Of Moderate Plaque-Type Scalp And Body Psoriasis Study Listed on ClinicalStudyDataRequest.com
114748 Completed A randomized, double blind, placebo-controlled three-way crossover study in mild asthmatics to evaluate the effect of smoking status on the attenuation by inhaled corticosteroids of the allergen-induced asthmatic response. Study Listed on ClinicalStudyDataRequest.com
114749 Completed A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
114778 Completed Immunogenicity and safety study of GSK Biologicals’ Boostrix™ vaccine using a new syringe presentation in healthy adolescents aged 10–15 years Study Listed on ClinicalStudyDataRequest.com
114791 Completed Assessing the safety of inhaled zanamivir exposure in pregnant women
114793 Completed Blinded retrospective laboratory evaluations to assess the serologic response to Porcine circovirus type 1 (PCV-1) in infants following the administration of GlaxoSmithKline (GSK) Biologicals’ human rotavirus vaccine (444563)
114840 Terminated A randomized, single blind, placebo-controlled, single ascending dose/repeat dose cohort study to assess safety, tolerability, pharmacokinetics and immunogenicity of GSK1223249 in patients with relapsing forms of multiple sclerosis. Study Listed on ClinicalStudyDataRequest.com
114855 Terminated A randomised, double-blind, placebo-controlled, parallel-group, multicentre study to determine the efficacy and safety of 2 doses of retigabine immediate release (900 mg/day and 600 mg/day) used as adjunctive therapy in adult Asian subjects with drug-resistant partial-onset seizures. Study Listed on ClinicalStudyDataRequest.com
114856 Completed A multidose study in subjects with type 2 diabetes mellitus to assess the pharmacokinetics and pharmacodynamics of albiglutide Study Listed on ClinicalStudyDataRequest.com
114919 Completed An open-label, randomised, crossover study to assess the relative bioavailability of different 2mg formulations of GSK2018682(S1P1 agonist) in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114930 Completed DB2114930: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
114940 Active, Not Recruiting USHO-11-3281: Predictors of stepping down asthma therapy: observational study and Fluticasone propionate-Salmeterol Combination Therapy outcomes study

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.